10x Genomics, Inc. Foreign Currency Transaction Gain (Loss), before Tax
10x Genomics, Inc. (TXG) reported Foreign Currency Transaction Gain (Loss), before Tax of $2.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-02-13
- 10x Genomics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2019-12-31 was $300.00K.
- 10x Genomics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2019-09-30 was -$100.00K.
- 10x Genomics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2018-12-31 was -$100.00K.
- 10x Genomics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2018-09-30 was -$100.00K.
- 10x Genomics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2025 was $2.50M.
- 10x Genomics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$2.10M, a 275.00% decline from fiscal 2023.
- 10x Genomics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2023 was $1.20M, a 500.00% increase from fiscal 2022.
- 10x Genomics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2022 was $200.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $2.50M 10-K · filed 2026-02-13 | ||||
| 2024-12-31 | -$2.10M 10-K · filed 2026-02-13 | $2.10M 10-K · filed 2025-02-13 | |||
| 2023-12-31 | $1.20M 10-K · filed 2026-02-13 | ||||
| 2022-12-31 | $200.00K 10-K · filed 2025-02-13 | ||||
| 2021-12-31 | -$900.00K 10-K · filed 2024-02-15 | ||||
| 2020-12-31 | $1.30M 10-K · filed 2023-02-16 | ||||
| 2019-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $200.00K derived: sum of 2 quarters · filed 2022-02-18 | $100.00K 10-K · filed 2022-02-18 | ||
| 2019-09-30 | -$100.00K 10-Q · filed 2019-11-12 | -$200.00K 10-Q · filed 2019-11-12 | |||
| 2018-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$200.00K derived: sum of 2 quarters · filed 2021-02-26 | -$300.00K 10-K · filed 2021-02-26 | ||
| 2018-09-30 | -$100.00K 10-Q · filed 2019-11-12 | -$200.00K 10-Q · filed 2019-11-12 | |||
| 2017-12-31 | $100.00K 10-K · filed 2020-02-27 |